Skip to content
Screener

Bausch Health Companies BHC Q4 2025 Annual earnings

Reported February 18, 2026 · After market close

Revenue$2.8BBeat by $57.8M
EPS$1.08Miss by $0.13
Revenue estimate$2.7B
EPS estimate$1.21

Next report

Oct 28, 2026 (in a month)
Revenue estimate$2.8B
EPS estimate$1.19

Financials

Q4 2025

Income statement

See full
Revenue$2.8B+9.3%
Operating income$474.0M-15.1%

Balance sheet

See full
Cash & equivalents$1.3B+10.3%
Total debt$21.0B-3.6%
Total equity-$554.0M+56.7%
Total assets$26.4B-0.6%

Cash flow

See full
Operating cash flow$495.0M-17.6%
CapEx$92.0M-13.2%
Free cash flow$403.0M-18.6%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$2.58B-13.1%
Enterprise value$22.3B-5.5%
P/S0.3×-0.1×

Profitability

See full
Operating margin17.7%+1.6pp
FCF margin9.8%-3.3pp

Returns & leverage

See full
Current ratio1.5×+0.6×

Segments

By segment

See full
Bausch + Lomb$1.4B+9.8%
Salix$693.0M+9.3%
International$306.0M+9.7%
Diversified$255.0M+11.8%
Solta Medical$137.0M-0.7%

FAQ

When did Bausch Health Companies report Q4 2025 earnings?
Bausch Health Companies (BHC) reported Q4 2025 earnings on February 18, 2026 after market close.
What were Bausch Health Companies's Q4 2025 revenue and EPS?
Bausch Health Companies reported revenue of $2.8B and eps of $1.08 for Q4 2025.
Did Bausch Health Companies beat estimates in Q4 2025?
Revenue beat the consensus estimate of $2.7B by $57.8M. EPS missed the consensus estimate of $1.21 by $0.13.
How did Bausch Health Companies's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 8.9% from $2.6B a year earlier and eps declined 6.1% from $1.15.
Where can I find Bausch Health Companies's Q4 2025 SEC filings?
You can read the 8-K earnings release (0000885590-26-000020) and the 10-K periodic report (0000885590-26-000023) directly on SEC EDGAR. The filing index links above go to sec.gov.